Safety and Tolerability of Sedation-Free Flexible Cystoscopy for Intradetrusor Botulinum Toxin-A Injection

Journal of Urology

Volumn 177, Issue 3, 2007, Pages 1006-1010

  Cohen, Brian L ^a   Rivera, Rolando ^a   Barboglio, Paholo ^a   Gousse, Angelo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

bladder; botulinum toxin type A; endoscopy; pain; urination disorders

Indexed keywords

BOTULINUM TOXIN A; LIDOCAINE; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYSTOSCOPE; CYSTOSCOPY; EVALUATION; FEMALE; HUMAN; INJECTION; MALE; NEEDLE; OVERACTIVE BLADDER; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; SEDATION; UROGENITAL ENDOSCOPY; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRAVESICAL; ANESTHETICS, LOCAL; BOTULINUM TOXIN TYPE A; CYSTOSCOPY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LIDOCAINE; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; URINARY BLADDER, OVERACTIVE;

EID: 33846849627     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.10.050     Document Type: Article

References (17)

1. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21 (2002) 167
2. Stewart W., VanRooyen J., Cundiff G., Abrams P., Herzog R., Corey T., et al. Prevalence and burden of overactive bladder in the United States. World J Urol 20 (2003) 327
3. Rajkumar G.N., Small D.R., Mustafa A.W., and Conn G. A prospective study to evaluate the safety, tolerability, efficacy, and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 96 (2005) 848
4. Schurch B., deSeze M., Denys P., Chartier-Kastler E., Haab F., Everaert K., et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174 (2005) 196
5. deSeze M., Petit H., Gallien P., deSeze M.P., Joseph P.A., Mazaux J.M., et al. Botulinum A toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. Eur Urol 42 (2002) 56
6. Zermann D., Ishigooka M., Schubert J., and Schmidt R.A. Persisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?. Eur Urol 38 (2000) 393
7. Doggweiler R., Zermann D.H., Ishigooka M., and Schmidt R.A. Botox-induced prostatic involution. Prostate 37 (1998) 44
8. Smith C.P., Nishiguchi J., Leary M., Yoshimura N., and Chancellor M. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urol 65 (2005) 37
9. Smith C.P., and Chancellor M.B. Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 19 (2005) 880
10. Bagi P., and Biering-Sorensen F. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions. Scand J Urol Nephrol 38 (2004) 495
11. Grosse J., Kramer G., and Stroher M. Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47 (2005) 653
12. Hajebrahimi S., Altaweel W., Cadoret J., Cohen E., and Corcos J. Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results. Can J Urol 12 (2005) 2543
13. Kuo H.C. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urol 63 (2004) 868
14. Harper M., Popat R.B., Dasgupta R., Fowler C.J., and Dasgupta P. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 92 (2003) 325
15. Schurch B., Reitz A., and Tenti G. Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor. Spinal Cord 42 (2004) 338
16. Schulte-Baukloh H., and Knipsel H.H. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 95 (2005) 454
17. Weisenfeld-Hallin Z. Sex differences in pain perception. Gend Med 2 (2005) 137